RESMED INC — Director's Dealing 2017

Nov 29, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-27

Reporting Person: McHale Richard (President, RC Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-27	ResMed Common Stock	A	3540	$84.63	Acquired	15535	Direct
2017-11-27	ResMed Common Stock	F	1331	$84.63	Disposed	14204	Direct

Footnotes

F1: Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted November 19, 2014, with a three-year performance period. The shares were earned and vested November 27, 2017, when the ResMed compensation committee certified performance.

F2: Shares earned based on performance at 57% of the target award.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.